The use of recombinant hemoglobin as an oxygen carrier in artificial blood substitutes has had limited success due to the toxicity of the free molecule. Now a team of researchers has produced a ...
New insights in how to better understand and control a severe side effect of hemoglobin-based oxygen carriers (HBOCs), often referred to as artificial blood, can be gained from a study New ...